The clinical nature and formal diagnosis of premenstrual, postpartum, and perimenopausal affective disorders.
Various mood and anxiety disorders are more prevalent in reproductive-aged women, and appear to be linked to hormonal and reproductive events. Premenstrual affective disorders consist of premenstrual syndrome, premenstrual dysphoric disorder, and premenstrual exacerbation of mood or anxiety disorders. Postpartum affective disorders can range from postpartum "blues" to postpartum depression with or without psychosis, and also include anxiety disorders, such as panic disorder, generalized anxiety disorder, social phobia, and obsessive-compulsive disorder. In perimenopausal women, the vulnerability to mood and anxiety disorders is increased. All of these disorders share risk factors, and have etiologic features in common, such as exposure to the rise and fall of ovarian sex steroids. The following is a review of these syndromes and their etiology, diagnosis, and treatment.
Rapkin
Andrea J
AJ
Department of Obstetrics and Gynecology, University of California, Los Angeles Medical Center, Box 951740, 27-139 CHS, Los Angeles, CA 90095, USA. arapkin@mednet.ucla.edu
Mikacich
Judith A
JA
Moatakef-Imani
Babak
B
Rasgon
Natalie
N
D000328:Adult; D017209:Apoptosis / Q000502:physiology; D001921:Brain / Q000378:metabolism; D002979:Climacteric / Q000097:blood*; D019052:Depression, Postpartum / Q000175:diagnosis* / Q000378:metabolism* / Q000628:therapy; D003937:Diagnosis, Differential; D004565:Electroconvulsive Therapy; D004958:Estradiol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008183:Luteal Phase / Q000378:metabolism; D008875:Middle Aged; D019964:Mood Disorders / Q000175:diagnosis* / Q000378:metabolism* / Q000628:therapy; D010053:Ovary / Q000378:metabolism; D011293:Premenstrual Syndrome / Q000175:diagnosis* / Q000378:metabolism* / Q000628:therapy; D018079:Receptors, GABA / Q000378:metabolism; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
D004958:Estradiol; D018079:Receptors, GABA; D017367:Selective Serotonin Reuptake Inhibitors